PLTR, the artificial intelligence and data analytics company best known for its Foundry, Gotham, and AIP platforms serving government and commercial clients, suffered a sharp reversal in Tuesday's trading session. After rallying 7% on Monday to close at $131.53, shares of Palantir Technologies plummeted 10.15% to $118.18, giving back all of the prior session's gains and then some. The sell-off was driven by a confluence of factors, including a global rout in AI and semiconductor stocks, intensifying scrutiny of the company's UK National Health Service contract, and pre-earnings repositioning ahead of the company's second-quarter report due August 3.
The most immediate catalyst for the decline was a sweeping sell-off across AI and semiconductor stocks that originated in Asian markets overnight. South Korea's Kospi index plunged more than 9%, while Japan's Nikkei 225 fell approximately 4%, as investors reassessed the scale and sustainability of AI infrastructure spending. The ripple effects reached U.S. futures well before the opening bell, with Nasdaq 100 futures sliding roughly 0.7% and S&P 500 futures easing about 0.3%. Nvidia (NVDA) remained under pressure, and the selling cascaded into other high-multiple AI names, including PLTR. The sell-off underscored how quickly sentiment can shift in the AI space when growth expectations collide with questions about the return on massive capital outlays.
Adding company-specific fuel to the sell-off, a Financial Times investigation published Tuesday delivered a significant blow to Palantir's narrative around its £330 million UK National Health Service contract. The analysis, conducted by the Health Foundation, found that Palantir's patient discharge tracking software showed no measurable impact on reducing NHS discharge delays — a direct contradiction to the company's prior claims of a 15% reduction. Internal NHS documents reportedly call for more rigorous evaluation of the platform, and multiple parliamentary committees, including the Health and Social Care Committee, have now urged the government to trigger the 2027 break clause and seek an alternative provider. With political opposition spanning the spectrum — from Labour MPs to Reform UK voters — and London Mayor Sadiq Khan already having blocked a separate Metropolitan Police contract with Palantir, the UK market has become an increasingly contentious front for the company.
Even after a year-to-date decline of roughly 31%, Palantir entered Tuesday trading at approximately 138 times trailing earnings and a price-to-sales ratio near 65x — among the richest multiples in large-cap software. At those levels, the stock is priced for near-flawless execution, which means any negative development — whether macro, political, or operational — triggers disproportionate selling. A Seeking Alpha analyst downgraded PLTR to bearish on Tuesday, specifically citing the company's "unsustainable" 38.3x forward sales multiple and warning of AI capital expenditure fatigue. With earnings just six days away, the high bar for Q2 results — following 85% revenue growth in Q1 — has left the stock vulnerable to profit-taking and defensive positioning.
The sell-off in PLTR came amid a volatile week for global markets, with investors bracing for the Federal Reserve's policy announcement and earnings from mega-cap names including Microsoft, Meta, Apple, and Amazon. Monday's session had seen Palantir rally sharply after Oppenheimer analyst Param Singh reaffirmed an Outperform rating and $200 price target, predicting a Q2 beat and guidance raise. But Tuesday's reversal was swift and decisive, with the stock breaking below the psychologically important $120 level and approaching its 52-week low of $106.37. The broader software sector struggled in sympathy, with Palo Alto Networks (PANW) and CrowdStrike (CRWD) also trading lower, though Palantir's decline was among the steepest given its elevated multiple and the compounding effect of the NHS headlines.
All eyes now turn to Palantir's second-quarter earnings report, scheduled for release after the market closes on Monday, August 3. Analysts expect another quarter of robust AI-driven growth, with U.S. commercial revenue likely to remain the standout metric. However, the company faces an increasingly high bar: after delivering 85% year-over-year revenue growth in Q1 and raising full-year guidance twice, even a strong report may not be enough to reverse the stock's 2026 downtrend if investors remain focused on valuation compression and geopolitical headwinds. The NHS contract review, ongoing legal disputes in London, and the broader AI spending debate will all feature prominently in the investment narrative. Additionally, Michael Burry's well-publicized short position continues to hang over the stock. With the Fed decision and Big Tech earnings due later this week, macro sentiment could either provide a tailwind or exacerbate the selling pressure on high-multiple names like PLTR.
In volatile market environments like the one currently facing Palantir and the broader AI sector, traders increasingly turn to automated strategies for disciplined, data-driven decision-making. Tickeron's Trending AI Robots page offers a curated selection of hundreds of AI-powered trading bots covering thousands of tickers, but only the strongest performers under current market conditions are featured. Bots vary by strategy, timeframe, performance metrics, and traded symbols, giving traders a diverse toolkit for navigating uncertain markets. Explore the Trending AI Robots to see which strategies are currently leading the pack.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
PLTR broke above its upper Bollinger Band on August 07, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 51 similar instances where the stock broke above the upper band. In of the 51 cases the stock fell afterwards. This puts the odds of success at .
The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 12 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PLTR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Momentum Indicator moved above the 0 level on August 04, 2026. You may want to consider a long position or call options on PLTR as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for PLTR just turned positive on August 04, 2026. Looking at past instances where PLTR's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .
PLTR moved above its 50-day moving average on August 04, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for PLTR crossed bullishly above the 50-day moving average on August 05, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a +3 3-day Advance, the price is estimated to grow further. Considering data from situations where PLTR advanced for three days, in of 334 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PLTR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (44.248) is normal, around the industry mean (22.706). P/E Ratio (153.795) is within average values for comparable stocks, (70.701). Projected Growth (PEG Ratio) (2.410) is also within normal values, averaging (2.165). PLTR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.021). P/S Ratio (75.188) is also within normal values, averaging (111.934).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows